First Drug for Rare Heart Condition Nears FDA Approval

After 27 years, biotech company Cytokinetics could win its second FDA approval in record time with a groundbreaking heart drug.

The medication would be the first treatment specifically designed for a type of inherited heart disease that affects thousands of Americans.